These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8445813)

  • 21. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice.
    Clifford CP; Adams DA; Murray S; Taylor GW; Wilkins MR; Boobis AR; Davies DS
    Eur J Clin Pharmacol; 1997; 52(4):311-5. PubMed ID: 9248771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emedastine-ketoconazole: pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
    Herranz U; Rusca A; Assandri A
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):102-9. PubMed ID: 11396749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population variability in the pharmacokinetics of terfenadine: the case for a pseudo-polymorphism with clinical implications.
    Honig PK; Smith JE; Wortham DC; Zamani K; Cantilena LR
    Drug Metabol Drug Interact; 1994; 11(2):161-8. PubMed ID: 12369599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative pharmacokinetic-pharmacodynamic study of the electrocardiographic effects of epinastine and terfenadine in rats.
    Ohtani H; Kotaki H; Sawada Y; Iga T
    J Pharm Pharmacol; 1997 Apr; 49(4):458-62. PubMed ID: 9232548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin.
    Morganroth J; Hunt T; Dorr MB; Magner D; Talbot GH
    Clin Ther; 1999 Sep; 21(9):1514-24. PubMed ID: 10509846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
    Kivistö KT; Neuvonen PJ; Klotz U
    Clin Pharmacokinet; 1994 Jul; 27(1):1-5. PubMed ID: 7955768
    [No Abstract]   [Full Text] [Related]  

  • 28. Torsades de pointes occurring in association with terfenadine use.
    Mathews DR; McNutt B; Okerholm R; Flicker M; McBride G
    JAMA; 1991 Nov; 266(17):2375-6. PubMed ID: 1920744
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the potential for a pharmacokinetic interaction between fluoxetine and terfenadine.
    Bergstrom RF; Goldberg MJ; Cerimele BJ; Hatcher BL
    Clin Pharmacol Ther; 1997 Dec; 62(6):643-51. PubMed ID: 9433393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of venlafaxine on the pharmacokinetics of terfenadine.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    Psychopharmacol Bull; 1998; 34(3):383-9. PubMed ID: 9803772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.
    Pohjola-Sintonen S; Viitasalo M; Toivonen L; Neuvonen P
    Eur J Clin Pharmacol; 1993; 45(2):191-3. PubMed ID: 8223844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
    Abbas R; Hug BA; Leister C; Sonnichsen D
    Int J Cancer; 2012 Aug; 131(3):E304-11. PubMed ID: 22065400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats.
    Ohtani H; Hanada E; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Sep; 19(9):1189-96. PubMed ID: 8889039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance.
    Rau SE; Bend JR; Arnold MO; Tran LT; Spence JD; Bailey DG
    Clin Pharmacol Ther; 1997 Apr; 61(4):401-9. PubMed ID: 9129557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM; Cavanaugh JH; Leese P; Kasier J; Cao G; Locke CS; Dube LM
    Eur J Clin Pharmacol; 1997; 52(1):49-54. PubMed ID: 9143867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terfenadine pharmacokinetics in breast milk in lactating women.
    Lucas BD; Purdy CY; Scarim SK; Benjamin S; Abel SR; Hilleman DE
    Clin Pharmacol Ther; 1995 Apr; 57(4):398-402. PubMed ID: 7712667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations.
    Brannan MD; Reidenberg P; Radwanski E; Shneyer L; Lin CC; Cayen MN; Affrime MB
    Clin Pharmacol Ther; 1995 Sep; 58(3):269-78. PubMed ID: 7554700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of axitinib on the QT interval in healthy volunteers.
    Ruiz-Garcia A; Houk BE; Pithavala YK; Toh M; Sarapa N; Tortorici MA
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):619-28. PubMed ID: 25589220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.